Latest Stories

M
Screener

3 Low-Volatility Stocks with Open Questions

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Jan 06, 2026
C
Screener

1 Healthcare Stock to Target This Week and 2 We Turn Down

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 17.2% over the past six months, topping the S&P 500 by 7.1 percentage points.

Jan 06, 2026
L
Screener

2 Russell 2000 Stocks on Our Watchlist and 1 We Ignore

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.

Jan 06, 2026
E
Screener

3 Stocks Under $10 That Fall Short

Investors can certainly boost their returns by concentrating on stocks trading between $1 and $10. However, a disciplined approach is necessary because many of these businesses are speculative and lack the underlying fundamentals to support their prices.

Jan 06, 2026
C
Screener

1 Growth Stock with Explosive Upside and 2 We Turn Down

Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.

Jan 06, 2026
S
Screener

3 Stocks Under $50 That Fall Short

Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and investors should exercise caution as some have shaky business models.

Jan 06, 2026
N
Three Reasons

Nvidia (NVDA): 3 Reasons We Love This Stock

Nvidia currently trades at $188.00 and has been a dream stock for shareholders. It’s returned 1,390% since January 2021, blowing past the S&P 500’s 82.9% gain. The company has also beaten the index over the past six months as its stock price is up 18.8% thanks to its solid quarterly results.

Jan 06, 2026
M
Three Reasons

Masco (MAS): Buy, Sell, or Hold Post Q3 Earnings?

Masco has been treading water for the past six months, recording a small loss of 1.9% while holding steady at $64.06. The stock also fell short of the S&P 500’s 10.1% gain during that period.

Jan 06, 2026
A
Three Reasons

3 Reasons ADBE is Risky and 1 Stock to Buy Instead

Over the past six months, Adobe’s shares (currently trading at $332.39) have posted a disappointing 11.8% loss, well below the S&P 500’s 10.1% gain. This might have investors contemplating their next move.

Jan 06, 2026
T
Three Reasons

3 Reasons to Avoid TECH and 1 Stock to Buy Instead

Bio-Techne’s 21% return over the past six months has outpaced the S&P 500 by 10.9%, and its stock price has climbed to $62.36 per share. This performance may have investors wondering how to approach the situation.

Jan 06, 2026